Prediction of relapse after discontinuation of tyrosine kinase inhibitor treatment in CML
Abstract
The achievement of a deep molecular response in patients with chronic myeloid leukemia (CML) receiving tyrosine kinase inhibitor (TKI) treatment has paved the way for treatment-free remission (TFR)...
Fields of Study & Subjects
Chronic Myeloid Leukemia Treatments
Chronic Lymphocytic Leukemia Research
graph theory and CDMA systems
Publication details
- Journal / source
- Leukemia & lymphoma/Leukemia and lymphoma
- Volume
- 67
- Issue
- 2
- Pages
- 243–245
- Publication date
- 5 January 2026
- Language
- EN